Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations

Fig. 2

Clinical effectiveness in undiscounted incremental life years (LYs) and undiscounted incremental quality-adjusted life years (QALYs) compared to standard care (intensified surveillance for breast cancer). incr.: incremental; LYs: Life years; PBM: Prophylactic bilateral mastectomy; PBSO: Prophylactic bilateral salpingo-oophorectomy; QALYs: quality-adjusted life years; y: years of age

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us